Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$951M |
| 2 |
Advanced Micro Devices
AMD
|
+$589M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$418M |
| 4 |
Lam Research
LRCX
|
+$412M |
| 5 |
Microsoft
MSFT
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$585M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$111M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$87.8M |
| 5 |
TSMC
TSM
|
+$70.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.05% |
| 2 | Financials | 11.79% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Lockheed Martin
LMT
$135B
| $1.01M | ﹤0.01% |
2,931
+347
| +13% | +$126K |
|
552
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| $1.01M | ﹤0.01% |
18,425
+3,459
| +23% | +$189K |
|
553
AMERISAFE
AMSF
$551M
| $994K | ﹤0.01% |
17,707
+2,503
| +16% | +$143K |
|
554
Affiliated Managers Group
AMG
$9.83B
| $992K | ﹤0.01% |
6,565
+8
| +0.1% | +$1.31K |
|
555
Workday
WDAY
$42B
| $984K | ﹤0.01% |
3,939
-238
| -6% | -$58.9K |
|
556
OraSure Technologies
OSUR
$275M
| $934K | ﹤0.01% |
82,622
+10,952
| +15% | +$120K |
|
557
Vanguard Dividend Appreciation ETF
VIG
$114B
| $931K | ﹤0.01% |
6,063
+3,937
| +185% | +$627K |
|
558
Central Pacific Financial
CPF
$1.01B
| $928K | ﹤0.01% |
36,148
+5,246
| +17% | +$131K |
|
|
FRLG
559
DELISTED
Large Cap Growth Index-Linked Exchange Traded Notes due 2028
FRLG
| $928K | ﹤0.01% |
3,054
-1,371
| -31% | -$441K |
|
560
Vanguard Energy ETF
VDE
$9.84B
| $924K | ﹤0.01% |
12,510
-1,510
| -11% | -$105K |
|
561
iShares California Muni Bond ETF
CMF
$4.61B
| $919K | ﹤0.01% |
14,806
+25
| +0.2% | +$1.57K |
|
562
Vanguard Industrials ETF
VIS
$8.36B
| $918K | ﹤0.01% |
4,886
+328
| +7% | +$64.3K |
|
563
State Street SPDR S&P Metals & Mining ETF
XME
$4.22B
| $899K | ﹤0.01% |
21,539
-58
| -0.3% | -$2.51K |
|
564
Lennar Class B
LEN.B
$20.1B
| $896K | ﹤0.01% |
12,154
| – | – |
|
565
iShares TIPS Bond ETF
TIP
$14.5B
| $896K | ﹤0.01% |
7,018
-393
| -5% | -$50.7K |
|
566
Broadstone Net Lease
BNL
$4.06B
| $890K | ﹤0.01% |
35,858
| – | – |
|
567
Eversource Energy
ES
$27.1B
| $879K | ﹤0.01% |
10,749
+287
| +3% | +$24.9K |
|
568
CVB Financial
CVBF
$4B
| $877K | ﹤0.01% |
43,031
+6,516
| +18% | +$129K |
|
569
Schwab US Dividend Equity ETF
SCHD
$105B
| $875K | ﹤0.01% |
35,343
+3,201
| +10% | +$81.4K |
|
570
Moderna
MRNA
$21.5B
| $872K | ﹤0.01% |
2,266
-697
| -24% | -$257K |
|
571
Bruker
BRKR
$7.8B
| $870K | ﹤0.01% |
11,134
-125
| -1% | -$10.4K |
|
572
Twilio
TWLO
$29.3B
| $868K | ﹤0.01% |
2,722
+1,853
| +213% | +$675K |
|
573
Casella Waste Systems
CWST
$5.75B
| $864K | ﹤0.01% |
11,371
+1,880
| +20% | +$132K |
|
574
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.34B
| $839K | ﹤0.01% |
3,556
+416
| +13% | +$102K |
|
575
Southside Bancshares
SBSI
$974M
| $831K | ﹤0.01% |
21,695
+3,726
| +21% | +$137K |
|
Similar funds
Ken Fisher's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Fisher held 1,103 positions worth $161B, up 1.1% from $159B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q3 2021 filing shows 93 new, 444 increased, 375 reduced and 75 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M. The largest sale was Visa, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M.
- Ken Fisher added most to Meta Platforms (Facebook) in Q3 2021, an estimated $951M increase.
- Ken Fisher's biggest Q3 2021 reduction was Visa, cutting an estimated $1.24B.
- Ken Fisher fully exited Stamps.com, Inc. in Q3 2021, selling an estimated $111M.
- Ken Fisher's ten largest holdings make up 31% of its $161B portfolio in Q3 2021.
- Ken Fisher opened 93 new positions and closed 75 in Q3 2021.
- Ken Fisher's portfolio value rose 1.1% quarter-over-quarter to $161B.
Based on Fisher Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.